Trials / Sponsors / Catherine Shu
Catherine Shu
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment Nonsmall Cell Lung Cancer | Phase 2 | 2022-12-01 |
| Completed | SGI-110 Plus Durvalumab/Tremelimumab in SCLC Extensive-stage Small Cell Lung Cancer | Phase 1 | 2017-12-15 |